SG10202101160RA - Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells - Google Patents

Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells

Info

Publication number
SG10202101160RA
SG10202101160RA SG10202101160RA SG10202101160RA SG10202101160RA SG 10202101160R A SG10202101160R A SG 10202101160RA SG 10202101160R A SG10202101160R A SG 10202101160RA SG 10202101160R A SG10202101160R A SG 10202101160RA SG 10202101160R A SG10202101160R A SG 10202101160RA
Authority
SG
Singapore
Prior art keywords
alleviation
treatment
stem cells
pluripotent stem
lung injury
Prior art date
Application number
SG10202101160RA
Inventor
Hiroshi Yabuki
Yoshinori Okada
Mari Dezawa
Original Assignee
Hiroshi Yabuki
Yoshinori Okada
Mari Dezawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hiroshi Yabuki, Yoshinori Okada, Mari Dezawa filed Critical Hiroshi Yabuki
Publication of SG10202101160RA publication Critical patent/SG10202101160RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/22—Materials or treatment for tissue regeneration for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
SG10202101160RA 2016-08-03 2017-08-03 Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells SG10202101160RA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016153264 2016-08-03

Publications (1)

Publication Number Publication Date
SG10202101160RA true SG10202101160RA (en) 2021-03-30

Family

ID=61073590

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10202101160RA SG10202101160RA (en) 2016-08-03 2017-08-03 Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells
SG11201900986YA SG11201900986YA (en) 2016-08-03 2017-08-03 Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201900986YA SG11201900986YA (en) 2016-08-03 2017-08-03 Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells

Country Status (9)

Country Link
US (1) US20190201456A1 (en)
EP (1) EP3494979A4 (en)
JP (1) JP7045670B2 (en)
KR (1) KR102464099B1 (en)
CN (1) CN109689074A (en)
AU (1) AU2017305067B2 (en)
CA (1) CA3032925A1 (en)
SG (2) SG10202101160RA (en)
WO (1) WO2018025976A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110772534A (en) * 2018-07-12 2020-02-11 南通大学 Application of multilineage differentiated persistent stress cells in the preparation of anti-inflammatory drugs
CN110772535A (en) * 2018-07-12 2020-02-11 南通大学 Application of multisystem differentiation sustained stress cells in preparation of analgesic drugs
CN110585242A (en) * 2019-10-15 2019-12-20 南通大学 Application of multisystem differentiation continuous stress cells, medicine for treating diabetes and preparation method of medicine
CN112471140A (en) * 2020-12-22 2021-03-12 华中科技大学 Protective solution for cell strain cryopreservation resuscitation and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101864392B (en) 2005-12-13 2016-03-23 国立大学法人京都大学 Nuclear reprogramming factor
US20120269774A1 (en) * 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
JP2014133703A (en) * 2011-03-30 2014-07-24 Clio Inc Composition for cell therapy for allotransplant including ssea-3 positive pluripotent stem cell that can be isolated from biological tissue
US9550975B2 (en) 2009-07-15 2017-01-24 Mari Dezawa SSEA-3 pluripotent stem cell isolated from body tissue
CA2829586C (en) * 2011-03-11 2021-03-02 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
WO2014027474A1 (en) * 2012-08-17 2014-02-20 株式会社Ｃｌｉｏ Pluripotent stem cell that induces repair and regeneration after myocardial infarction
TW201441369A (en) * 2012-12-21 2014-11-01 Univ Rutgers MUSE cells isolation and expansion
JP6519038B2 (en) * 2014-02-26 2019-05-29 株式会社生命科学インスティテュート Pluripotent stem cells for the treatment of cerebral infarction

Also Published As

Publication number Publication date
EP3494979A1 (en) 2019-06-12
KR102464099B1 (en) 2022-11-08
CN109689074A (en) 2019-04-26
JPWO2018025976A1 (en) 2019-06-06
WO2018025976A1 (en) 2018-02-08
EP3494979A4 (en) 2020-03-04
SG11201900986YA (en) 2019-02-27
JP7045670B2 (en) 2022-04-01
US20190201456A1 (en) 2019-07-04
AU2017305067B2 (en) 2022-11-03
CA3032925A1 (en) 2018-02-08
AU2017305067A1 (en) 2019-02-28
KR20190039700A (en) 2019-04-15

Similar Documents

Publication Publication Date Title
IL274568A (en) Cot modulators and methods of use thereof
GB2595063B (en) Modified cells and methods of therapy
SG11201803043VA (en) Derivation of human skin organoids from pluripotent stem cells
EP3334820C0 (en) Induced extended pluripotent stem cells, methods of making and using
IL249287B (en) Methods of increasing tonic inhibition and treating secondary insomnia
IL249580A0 (en) Methods of anesthetizing nerve tissue in the trigeminal nerve pathway and medical uses thereof
IL256515A (en) Therapeutic peptides and methods of use thereof
IL263265A (en) Use of mesenchymal stem cells and parts thereof
IL282482A (en) Protoxin-ii variants and methods of use
PL3212204T3 (en) Micronized eggshell membrane particles and the use thereof to promote the healing of wounds
SG11201702316SA (en) Monolayer of pbmcs or bone-marrow cells and uses thereof
IL265881A (en) Inhaler and methods of use thereof
SG11201607881SA (en) Methods of treating nail and scalp psoriasis
IL282508A (en) Protoxin-ii variants and methods of use
ZA201704726B (en) Peptides and their use in the treatment of skin
GB201404403D0 (en) Compositions and methods relating to the treatment of diseases
RS64703B1 (en) Indolinone compounds and their use in the treatment of fibrotic diseases
SG10202101160RA (en) Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells
ZA201604870B (en) Recombinant microorganisms and methods of use thereof
SG11201706471QA (en) Treatment and resourcelization of acid waste gas
SG11201704486TA (en) Improvements in and relating to the treatment of matrices and/or the contents of matrices
GB2546965B (en) Improvements in and relating to the treatment of arthrofibrosis
GB201605127D0 (en) Composition and methods of treatment
GB201404265D0 (en) Respiratory analysis and treatment
GB201421263D0 (en) Improvements in and relating to the treatment of matrices and/or the content ofmatrices